查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933383

生物植入物市场规模、占有率、成长、全球产业分析：依类型、应用、区域洞察和预测（2026-2034 年）

Bio-Implants Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

生物植入物市场成长驱动因素

预计到 2025 年，全球生物植入物市场将呈现强劲成长，达到 199.6 亿美元。受慢性病、骨科疾病和心血管疾病发病率上升以及重建手术需求增加的推动，该市场持续稳定扩张。报告显示，预计该市场将从 2026 年的 216.8 亿美元成长到 2034 年的 429.5 亿美元，预测期内复合年增长率 (CAGR) 为 8.92%。北美地区凭藉先进的医疗基础设施和较高的手术量，在 2025 年将以 46.31% 的市占率领先。

生物植入物是指植入人体以取代或补充受损组织、骨骼或器官的医疗器材或生物材料。这些植入物的设计旨在确保生物相容性、机械强度和长期安全性。技术先进的植入物日益普及，加上人口老化加剧，正显着推动全球市场成长。

市场动态

市场驱动因素

慢性病和退化性疾病发生率上升

肌肉骨骼疾病、心血管疾病和牙科疾病的日益普遍是生物植入物市场的主要驱动因素。北美、欧洲和日本等地区的人口老化增加了关节退化、骨折和瓣膜性心臟病的风险，从而推动了对骨科和心血管植入物的需求。此外，创伤病例的增加以及事故后重建手术的增加也持续推动植入物的应用。

市场限制因子

长期生物相容性有限及免疫排斥风险

儘管技术不断进步，长期生物相容性仍然是一个挑战。某些金属基和组织衍生植入物会随着时间的推移引发发炎和免疫反应，促使植入失败和再次手术。这些併发症会增加医疗成本，并限制先进植入技术的广泛应用。

市场机会

日益关注先进生物材料与再生医学技术

生物可吸收支架、组织工程移植物和3D列印客製化植入物等先进生物材料的开发正在创造巨大的成长机会。数位化手术规划、人工智慧驱动建模和机器人辅助植入的整合正在提高手术精度和患者预后。 2025年3月，Materialze公司启动了可生物吸收的3D列印支气管支架的临床试验，凸显了创新驱动的成长。

生物植入物市场趋势

对病患特异性和再生医学植入解决方案的需求日益增长

最显着的趋势之一是患者特异性植入物的日益普及。客製化的3D列印植入物可以改善解剖结构的贴合度，缩短恢復时间，并提高长期治疗效果。此外，含有干细胞和生长因子的再生医学植入物也越来越受到关注。 2024年4月，3D Systems公司获得FDA批准，其患者特异性颅骨植入物进一步推动了这一趋势。

市场挑战

严格的监管和品质合规要求

生物植入物製造商面临各地区严格的监管架构。 广泛的临床试验、材料验证以及符合FDA、CE和其他监管机构的要求都会增加研发时间和成本，这对中小企业构成挑战。

市场区隔分析

依产品类型

骨科植入物细分市场引领市场，预计到2026年将占47.53%的市场占有率，这主要得益于关节置换手术和肌肉骨骼疾病的增加。预计牙科植体细分市场在预测期内将以10.0%的复合年增长率成长。

依材料

组织衍生材料在2025年引领市场，预计到2026年仍将保持主导地位，市场占有率将达到62.66%，这主要归功于其优异的生物相容性和再生性能。预计聚合物细分市场将以8.9%的复合年增长率成长。

依最终使用者划分

医院和专科诊所占市场主导地位，预计到 2026 年将占 79.13% 的市场占有率，这主要得益于先进的手术基础设施和高手术量。

区域展望

北美将引领市场，预计 2025 年市场规模将达到 99.5 亿美元，到 2026 年将成长至 100.4 亿美元。光是美国一地，预计到 2026 年市场规模就将达到 90.4 亿美元，主要得益于高手术量和先进植入物的早期应用。

预计到 2025 年，欧洲市场规模将达到 57.4 亿美元，而亚太地区预计到 2025 年将达到 33.7 亿美元。由于医疗保健行业的扩张和投资的增加，预计该地区将呈现最快的成长速度。

到2025年，拉丁美洲和中东及非洲的市场规模将分别达到9.1亿美元和5.1亿美元。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要疾病流行情形、主要国家及地区（2025/2026年）
  • 生物植入物技术进步
  • 新产品发布、主要参与者
  • 关键产业趋势併购、收购与合作

第五章：全球生物植入物市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 依产品类型划分
    • 骨科植入物
    • 牙科植体
    • 心血管植入物
    • 整形与重建外科
    • 其他
  • 市场分析、洞察与预测 - 依材料划分
    • 金属与合金
    • 聚合物
    • 组织衍生性材料
    • 陶瓷
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 医院和专科诊所
    • 门诊手术中心（ASCs）
    • 学术和研究机构
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美生物植入物市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲生物植入物市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太生物植入物市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳大利亚
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲生物植入物市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第十章 中东和非洲生物植入物市场分析、洞察与预测（2021-2034 年）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2026 年）
  • 公司简介
  • Johnson &Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Smith+Nephew plc
  • Edwards Lifesciences Corporation
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Coloplast A/S
Product Code: FBI114437

Growth Factors of bio-implants Market

The global bio-implants market demonstrated strong performance in 2025, with a market valuation of USD 19.96 billion. Driven by rising incidences of chronic diseases, orthopedic disorders, cardiovascular conditions, and increasing demand for reconstructive surgeries, the market is witnessing steady expansion. According to the report, the market is projected to grow from USD 21.68 billion in 2026 to USD 42.95 billion by 2034, registering a CAGR of 8.92% during the forecast period. In 2025, North America dominated the market with a share of 46.31%, supported by advanced healthcare infrastructure and high procedure volumes.

Bio-implants are medical devices or biomaterials implanted into the human body to replace or support damaged tissues, bones, or organs. These implants are engineered to ensure biocompatibility, mechanical strength, and long-term safety. Growing adoption of technologically advanced implants, coupled with the rising geriatric population, is significantly boosting global market growth.

Market Dynamics

Market Drivers

Rising Incidence of Chronic and Degenerative Disorders

The increasing prevalence of musculoskeletal disorders, cardiovascular diseases, and dental conditions is a major driver of the bio-implants market. Aging populations across regions such as North America, Europe, and Japan are more susceptible to joint degeneration, fractures, and heart valve disorders, increasing demand for orthopedic and cardiovascular implants. Additionally, the growing number of trauma cases and post-accident reconstructive surgeries continues to accelerate implant adoption.

Market Restraints

Limited Long-Term Biocompatibility and Risk of Immune Rejection

Despite technological advancements, long-term biocompatibility remains a challenge. Certain metal-based and tissue-derived implants may trigger inflammatory or immune responses over time, leading to implant failure or revision surgeries. These complications increase healthcare costs and limit widespread adoption of advanced implant technologies.

Market Opportunities

Rising Focus on Advanced Biomaterials and Regenerative Technologies

The development of advanced biomaterials such as bioresorbable scaffolds, tissue-engineered grafts, and 3D-printed customized implants is creating significant growth opportunities. Integration of digital surgical planning, AI-driven modeling, and robotic-assisted implantation is improving surgical precision and patient outcomes. In March 2025, Materialise entered a clinical trial for its bioresorbable 3D-printed tracheobronchial splint, highlighting innovation-driven growth.

Bio-Implants Market Trends

Growing Preference for Patient-Specific and Regenerative Implant Solutions

One of the most prominent trends is the increasing adoption of patient-specific implants. Customized 3D-printed implants improve anatomical fit, reduce recovery time, and enhance long-term outcomes. Additionally, regenerative implants incorporating stem cells and growth factors are gaining traction. In April 2024, 3D Systems received FDA approval for a patient-specific cranial implant, reinforcing this trend.

Market Challenges

Stringent Regulatory and Quality Compliance Requirements

Bio-implant manufacturers face strict regulatory frameworks across regions. Extensive clinical testing, material validation, and compliance with FDA, CE, and other regulatory bodies increase development timelines and costs, posing a challenge for smaller players.

Segmentation Analysis

By Product Type

The orthopedic implants segment dominated the market, holding 47.53% share in 2026, driven by increasing joint replacement surgeries and musculoskeletal disorders. The dental implants segment is projected to grow at a CAGR of 10.0% during the forecast period.

By Material

Tissue-derived materials led the market in 2025 and are expected to dominate 2026 with a 62.66% share, due to superior biocompatibility and regenerative properties. The polymer segment is projected to grow at a CAGR of 8.9%.

By End User

Hospitals & specialty clinics dominated the market, accounting for 79.13% share in 2026, due to availability of advanced surgical infrastructure and high procedure volumes.

Regional Outlook

In 2025, North America led the market with a valuation of USD 9.95 billion, rising to USD 10.04 billion in 2026. The U.S. alone reached USD 9.04 billion in 2026, supported by high surgical volumes and early adoption of advanced implants.

Europe recorded a valuation of USD 5.74 billion in 2025, while Asia Pacific reached USD 3.37 billion in 2025 and is expected to register the fastest growth due to healthcare expansion and rising investments.

Latin America and Middle East & Africa reached USD 0.91 billion and USD 0.51 billion respectively in 2025.

Competitive Landscape

The market is semi-consolidated, with leading players such as Johnson & Johnson, Medtronic, Stryker, Abbott, and Boston Scientific focusing on innovation, partnerships, and geographic expansion. Continuous product launches and regulatory approvals remain key competitive strategies.

Conclusion

The global bio-implants market exhibited strong growth in 2025, supported by rising chronic disease prevalence, technological advancements, and increasing surgical procedures. With the market projected to grow from USD 21.68 billion in 2026 to USD 42.95 billion by 2034, the industry is set to witness sustained expansion at a CAGR of 8.92%. North America continues to dominate, while Asia Pacific is emerging as a high-growth region. Advancements in patient-specific implants, regenerative biomaterials, and digital surgical technologies are expected to play a crucial role in shaping the future of the bio-implants market through 2034.

Segmentation By Product Type, Material, End User, and Region

By Product Type * Orthopedic Implants

  • Dental Implants
  • Cardiovascular Implants
  • Plastic & Reconstructive Surgery
  • Others

By Material * Metals & Alloys

  • Polymers
  • Tissue Derived Materials
  • Ceramics
  • Others

By End User * Hospitals & Specialty Clinics

  • Ambulatory Surgical Centers (ASCs)
  • Academic & Research Institutes

By Geography * North America (By Product Type, Material, End User, and Country)

    • U.S.
      • By Product Type
    • Canada
      • By Product Type
  • Europe (By Product Type, Material, End User, and Country/Sub-region)
    • Germany
      • By Product Type
    • U.K.
      • By Product Type
    • France
      • By Product Type
    • Spain
      • By Product Type
    • Italy
      • By Product Type
    • Scandinavia
      • By Product Type
    • Rest of Europe
      • By Product Type
  • Asia Pacific (By Product Type, Material, End User, and Country/Sub-region)
    • China
      • By Product Type
    • Japan
      • By Product Type
    • India
      • By Product Type
    • Australia
      • By Product Type
    • Southeast Asia
      • By Product Type
    • Rest of Asia Pacific
      • By Product Type
  • Latin America (By Product Type, Type, Application, Technology, End User, and Country/Sub-region)
    • Brazil
      • By Product Type
    • Mexico
      • By Product Type
    • Rest of Latin America
      • By Product Type
  • Middle East and Africa (By Product Type, Type, Application, Technology, End User, and Country/Sub-region)
    • GCC
      • By Product Type
    • Saudi Arabia
      • By Product Type
    • Rest of Middle East and Africa
      • By Product Type

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. Technological Advancements in Bio-Implants
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Orthopedic Implants
    • 5.1.2. Dental Implants
    • 5.1.3. Cardiovascular Implants
    • 5.1.4. Plastic & Reconstructive Surgery
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Material
    • 5.2.1. Metals & Alloys
    • 5.2.2. Polymers
    • 5.2.3. Tissue Derived Materials
    • 5.2.4. Ceramics
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & Specialty Clinics
    • 5.3.2. Ambulatory Surgical Centres (ASCs)
    • 5.3.3. Academic & Research Institutes
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa

6. North America Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Orthopedic Implants
    • 6.1.2. Dental Implants
    • 6.1.3. Cardiovascular Implants
    • 6.1.4. Plastic & Reconstructive Surgery
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Material
    • 6.2.1. Metals & Alloys
    • 6.2.2. Polymers
    • 6.2.3. Tissue Derived Materials
    • 6.2.4. Ceramics
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & Specialty Clinics
    • 6.3.2. Ambulatory Surgical Centres (ASCs)
    • 6.3.3. Academic & Research Institutes
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Product Type
    • 6.4.2. Canada
      • 6.4.2.1. By Product Type

7. Europe Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Orthopedic Implants
    • 7.1.2. Dental Implants
    • 7.1.3. Cardiovascular Implants
    • 7.1.4. Plastic & Reconstructive Surgery
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Material
    • 7.2.1. Metals & Alloys
    • 7.2.2. Polymers
    • 7.2.3. Tissue Derived Materials
    • 7.2.4. Ceramics
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & Specialty Clinics
    • 7.3.2. Ambulatory Surgical Centres (ASCs)
    • 7.3.3. Academic & Research Institutes
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Product Type
    • 7.4.2. Germany
      • 7.4.2.1. By Product Type
    • 7.4.3. France
      • 7.4.3.1. By Product Type
    • 7.4.4. Spain
      • 7.4.4.1. By Product Type
    • 7.4.5. Italy
      • 7.4.5.1. By Product Type
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Product Type
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Product Type

8. Asia Pacific Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Orthopedic Implants
    • 8.1.2. Dental Implants
    • 8.1.3. Cardiovascular Implants
    • 8.1.4. Plastic & Reconstructive Surgery
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Material
    • 8.2.1. Metals & Alloys
    • 8.2.2. Polymers
    • 8.2.3. Tissue Derived Materials
    • 8.2.4. Ceramics
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Ambulatory Surgical Centres (ASCs)
    • 8.3.3. Academic & Research Institutes
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Product Type
    • 8.4.2. Australia
      • 8.4.2.1. By Product Type
    • 8.4.3. China
      • 8.4.3.1. By Product Type
    • 8.4.4. India
      • 8.4.4.1. By Product Type
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Product Type
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Product Type

9. Latin America Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Orthopedic Implants
    • 9.1.2. Dental Implants
    • 9.1.3. Cardiovascular Implants
    • 9.1.4. Plastic & Reconstructive Surgery
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Material
    • 9.2.1. Metals & Alloys
    • 9.2.2. Polymers
    • 9.2.3. Tissue Derived Materials
    • 9.2.4. Ceramics
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & Specialty Clinics
    • 9.3.2. Ambulatory Surgical Centres (ASCs)
    • 9.3.3. Academic & Research Institutes
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Product Type
    • 9.4.2. Mexico
      • 9.4.2.1. By Product Type
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Product Type

10. Middle East and Africa Bio-Implants Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Orthopedic Implants
    • 10.1.2. Dental Implants
    • 10.1.3. Cardiovascular Implants
    • 10.1.4. Plastic & Reconstructive Surgery
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Material
    • 10.2.1. Metals & Alloys
    • 10.2.2. Polymers
    • 10.2.3. Tissue Derived Materials
    • 10.2.4. Ceramics
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & Specialty Clinics
    • 10.3.2. Ambulatory Surgical Centres (ASCs)
    • 10.3.3. Academic & Research Institutes
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
      • 10.4.1.1. By Product Type
    • 10.4.2. South Africa
      • 10.4.2.1. By Product Type
    • 10.4.3. Rest of Middle East and Africa
      • 10.4.3.1. By Product Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Johnson & Johnson
    • 11.2.2. Medtronic plc
    • 11.2.3. Stryker Corporation
    • 11.2.4. Zimmer Biomet Holdings, Inc.
    • 11.2.5. Abbott Laboratories
    • 11.2.6. Boston Scientific Corporation
    • 11.2.7. Smith+Nephew plc
    • 11.2.8. Edwards Lifesciences Corporation
    • 11.2.9. B. Braun Melsungen AG
    • 11.2.10. Integra LifeSciences Holdings Corporation
    • 11.2.11. Coloplast A/S

List of Tables

  • Table 1: Global Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 3: Global Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 4: Global Bio-Implants Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 6: North America Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 7: North America Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 8: North America Bio-Implants Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 9: U.S. Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 10: Canada Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 11: Europe Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 13: Europe Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 14: Europe Bio-Implants Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 15: UK Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Germany Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: France Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 18: Spain Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 19: Italy Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 20: Scandinavia Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 21: Rest of Europe Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Asia Pacific Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Asia Pacific Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 24: Asia Pacific Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 25: Asia Pacific Bio-Implants Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 26: Japan Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 27: Australia Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 28: China Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 29: India Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: South East Asia Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 31: Rest of Asia Pacific Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Latin America Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 33: Latin America Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 34: Latin America Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 35: Latin America Bio-Implants Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 36: Brazil Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Mexico Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 38: Rest of Latin America Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 39: Middle East and Africa Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 40: Middle East and Africa Bio-Implants Market Revenue (USD billion) Forecast, by Material, 2021-2034
  • Table 41: Middle East and Africa Bio-Implants Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 42: Middle East and Africa Bio-Implants Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 43: GCC Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 44: Saudi Arabia Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 45: Rest of Middle East and Africa Bio-Implants Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

List of Figures

  • Figure 1: Global Bio-Implants Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 2: Global Bio-Implants Market Value Share (%), by Product Type, 2026 & 2034
  • Figure 3: Global Bio-Implants Market Value Share (%), by Material, 2026 & 2034
  • Figure 4: Global Bio-Implants Market Value Share (%), by End-user, 2026 & 2034
  • Figure 5: Global Bio-Implants Market Value (USD billion), by Region, 2026 & 2034
  • Figure 6: North America Bio-Implants Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 7: North America Bio-Implants Market Value Share (%), by Product Type, 2026
  • Figure 8: North America Bio-Implants Market Value (USD billion), by Material, 2026 & 2034
  • Figure 9: North America Bio-Implants Market Value Share (%), by Material, 2026
  • Figure 10: North America Bio-Implants Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 11: North America Bio-Implants Market Value Share (%), by End-user, 2026
  • Figure 12: North America Bio-Implants Market Value (USD billion), By Country, 2026 & 2034
  • Figure 13: North America Bio-Implants Market Value Share (%), By Country, 2026
  • Figure 14: Europe Bio-Implants Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 15: Europe Bio-Implants Market Value Share (%), by Product Type, 2026
  • Figure 16: Europe Bio-Implants Market Value (USD billion), by Material, 2026 & 2034
  • Figure 17: Europe Bio-Implants Market Value Share (%), by Material, 2026
  • Figure 18: Europe Bio-Implants Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 19: Europe Bio-Implants Market Value Share (%), by End-user, 2026
  • Figure 20: Europe Bio-Implants Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 21: Europe Bio-Implants Market Value Share (%), By Country/Sub-region, 2026
  • Figure 22: Asia Pacific Bio-Implants Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 23: Asia Pacific Bio-Implants Market Value Share (%), by Product Type, 2026
  • Figure 24: Asia Pacific Bio-Implants Market Value (USD billion), by Material, 2026 & 2034
  • Figure 25: Asia Pacific Bio-Implants Market Value Share (%), by Material, 2026
  • Figure 26: Asia Pacific Bio-Implants Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 27: Asia Pacific Bio-Implants Market Value Share (%), by End-user, 2026
  • Figure 28: Asia Pacific Bio-Implants Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 29: Asia Pacific Bio-Implants Market Value Share (%), By Country/Sub-region, 2026
  • Figure 30: Latin America Bio-Implants Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 31: Latin America Bio-Implants Market Value Share (%), by Product Type, 2026
  • Figure 32: Latin America Bio-Implants Market Value (USD billion), by Material, 2026 & 2034
  • Figure 33: Latin America Bio-Implants Market Value Share (%), by Material, 2026
  • Figure 34: Latin America Bio-Implants Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 35: Latin America Bio-Implants Market Value Share (%), by End-user, 2026
  • Figure 36: Latin America Bio-Implants Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 37: Latin America Bio-Implants Market Value Share (%), By Country/Sub-region, 2026
  • Figure 38: Middle East and Africa Bio-Implants Market Value (USD billion), by Product Type, 2026 & 2034
  • Figure 39: Middle East and Africa Bio-Implants Market Value Share (%), by Product Type, 2026
  • Figure 40: Middle East and Africa Bio-Implants Market Value (USD billion), by Material, 2026 & 2034
  • Figure 41: Middle East and Africa Bio-Implants Market Value Share (%), by Material, 2026
  • Figure 42: Middle East and Africa Bio-Implants Market Value (USD billion), by End-user, 2026 & 2034
  • Figure 43: Middle East and Africa Bio-Implants Market Value Share (%), by End-user, 2026
  • Figure 44: Middle East and Africa Bio-Implants Market Value (USD billion), By Country/Sub-region, 2026 & 2034
  • Figure 45: Middle East and Africa Bio-Implants Market Value Share (%), By Country/Sub-region, 2026
  • Figure 46: Global Bio-Implants Market Share (%), By Company, 2026